🔎 Trials Near Me

Home › NCT04994873

Skills to Enhance Positivity in Suicidal Youth

Recruiting

Skills to Enhance Positivity in Adolescents at Risk for Suicide

Who can join

Ages 12 to 60 · All sexes

Full eligibility criteria
Inclusion Criteria: Patients

* Ages 12- 60 years
* hospitalized on an inpatient psychiatric unit due to suicide risk
* past month suicide attempts or suicidal ideation
* proficient in English (parent either English or Spanish
* access to a smart phone.

Inclusion Criteria: Stakeholders

Ages 22 - 60 years

* work with adolescents hospitalized on an inpatient psychiatric unit due to suicide risk
* proficient in English or Spanish

Exclusion Criteria:

* active psychotic disorder
* significant cognitive impairment or deficits
* ward of the State
* discharge to residential facility.

About the study

This is a Hybrid Type I Effectiveness-Implementation design. Specifically, this study proposes to test the effectiveness of STEP in reducing suicidal events and ideation in 216 adolescents, admitted to inpatient psychiatric care due to suicide risk. Participants will be randomized to either STEP or ETAU. STEP involves 4 in-person sessions (3 individual, 1 family) focused on psychoeducation regarding positive and negative affect, mindfulness meditation, gratitude, and savoring. Mood monitoring prompts and skill reminders will be sent daily for the first month post-discharge and three times a week for the following two months. The ETAU condition will receive reminders to log into a safety resource app, matched in frequency to the STEP group. Effectiveness aspects of the design include using clinical staff as interventionists and having very few exclusion criteria.

What is being tested

Sponsor: Brown University · Participants: 216 · Started: Oct 4, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT04994873

Locations in the U.S.

MassachusettsChildren's Hospital, Boston
Rhode IslandButler Hospital, Providence
Bradley Hospital, Riverside

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.